Other languages Betta Pharmaceuticals Co., Ltd.

Equities

300558

CNE100002DD9

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-21 pm EDT			5-day change	1st Jan Change
39.4 ^CNY	+0.13%		-3.43%	-23.57%

Apr. 19	Betta Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Jan. 04	C4 Therapeutics, Inc. announced that it has received $24.999997 million in funding from Betta Pharmaceuticals Co., Ltd.	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Betta Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 19
Betta Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-24
Betta Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25
Betta Pharmaceuticals Gets Nod for Voronib Tablets' Listing	23-06-09
Betta Pharmaceuticals Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 15 June 2023	23-06-08
C4 Therapeutics, Betta Pharmaceuticals Sign Deal to Develop, Commercialize CFT8919 in Greater China	23-05-30
C4 Therapeutics and Betta Pharmaceuticals Announce Exclusive Licensing Agreement for the Development and Commercialization in Greater China of CFT8919, an Orally Bioavailable BiDAC Degrader of EGFR L858R for NSCLC	23-05-30
Betta Pharmaceuticals Co., Ltd. Approves Cash Dividend for the Year of 2022	23-05-16
Betta Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27
Betta Pharmaceuticals Co., Ltd. Announces Profit Distribution Proposal for 2022	23-04-24
Betta Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-23
Betta Pharmaceuticals Gets Nod to Start Clinical Trial of Tumor Drug in China	23-03-14
Betta Pharmaceuticals Co., Ltd. Approves Board Elections	22-12-28
Betta Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28
Betta Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-24
Betta Pharmaceuticals Co., Ltd. Announces Cash Dividend for 2021, Payable on 30 May 2022	22-05-23
EyePoint Pharmaceuticals Grants Betta Pharmaceuticals Rights to Commercialize Chronic Eye Disorder Treatment in China	22-05-04
Betta Pharmaceuticals Co., Ltd. Approves 2021 Profit Distribution Plan	22-04-29
Betta Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-26
Betta Pharmaceuticals Co., Ltd. Proposes Final Cash Dividend for 2021	22-04-07

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Betta Pharmaceuticals Co., Ltd.

Equities

300558

CNE100002DD9

Other languages

Filters